Price $83.58 |
Market Cap
149.91B
|
Sector Health Care |
Div. Growth
10.10%
|
|
P/E
51.9
|
P/B
4.76
|
P/S
4.88
|
Dividend %
1.50%
|
|
P/CF
-
|
P/FCF
76.6
|
Op. Cash Flow
5.72M
|
FCF
1.1
|
|
Op. Margin
12.80%
|
Net Margin
9.40%
|
ROE
9.40%
|
ROI
6.10%
|
|
ROA
4.20%
|
EPS Growth
211.10%
|
Current Ratio
1.6
|
Debt/Equity
63.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.26 | - | - | 11.6M | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.22 | - | - | 29.5M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $1.38 | - | - | 94.6M | Strong Buy |
| Natus Medical Inc (NTUS) | $31.26 | - | - | 954.3M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $22.86 | - | - | 7.58B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
